Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.

Itsuto Hamano Shingo HatakeyamaShintaro NaritaMasahiro TakahashiToshihiko SakuraiSadafumi KawamuraSenji HoshiMasanori IshidaToshiaki KawaguchiShigeto IshidoyaJiro ShimodaHiromi SatoKoji MitsuzukaTatsuo TochigiNorihiko TsuchiyaYoichi AraiTomonori HabuchiChikara Ohyama

Published in: World journal of urology (2019)

Higher PSA nadir and shorter TTN during the initial ADT are poor prognostic factors in patients with mCRPC.

Keyphrases

prognostic factors
prostate cancer
radical prostatectomy
mesenchymal stem cells
bone marrow
smoking cessation
replacement therapy